The Utility of CAPTEM in Chemo-Resistant Neuroendocrine TumorsByRobert L. Fine, MDApril 24th 2014Robert L. Fine, MD, from Columbia University, comments on the utility of CAPTEM in chemotherapy-resistant neuroendocrine tumors.
Reducing the Risk of Relapse in Patients With Pancreatic CancerByRobert L. Fine, MDFebruary 24th 2014Robert L. Fine, MD, from Columbia University, discusses reducing the risk of relapse in patients with pancreatic cancer.